Find Grants for Large Businesses
Find out if you qualify for verified grants for Large Businesses . Discover your eligibility and key funding details for Large Businesses from major foundations and government agencies.
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
Deadline: November 10, 2026
Opportunity Number: RFA-NS-26-001
Agency: National Institutes of Health
Open Date: May 4, 2026
Close Date: November 10, 2026
Status: Posted
CFDA Numbers: 93.853
BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)
Deadline: February 11, 2027
Opportunity Number: RFA-DC-27-004
Agency: National Institutes of Health
Open Date: May 4, 2026
Close Date: February 11, 2027
Status: Posted
CFDA Numbers: 93.242, 93.173, 93.286, 93.866, 93.273, 93.279, 93.865, 93.853, 93.213, 93.867
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
Deadline: July 5, 2029
Opportunity Number: PAR-27-072
Agency: National Institutes of Health
Open Date: May 4, 2026
Close Date: July 5, 2029
Status: Posted
CFDA Numbers: 93.399, 93.395, 93.865, 93.867, 93.393, 93.394, 93.396
CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)
Deadline: November 5, 2028
Opportunity Number: PAR-27-075
Agency: National Institutes of Health
Open Date: May 4, 2026
Close Date: November 5, 2028
Status: Posted
CFDA Numbers: 93.855, 93.279, 93.846
Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed)
Deadline: July 9, 2026
Opportunity Number: RFA-AI-27-012
Agency: National Institutes of Health
Open Date: May 4, 2026
Close Date: July 9, 2026
Status: Posted
CFDA Numbers: 93.855
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)
Deadline: March 5, 2027
Opportunity Number: PAR-27-081
Agency: National Institutes of Health
Open Date: May 4, 2026
Close Date: March 5, 2027
Status: Posted
CFDA Numbers: 93.866, 93.242, 93.867, 93.279
DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award
Deadline: September 30, 2026
Opportunity Number: HT942526ALSRPCOBA
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: September 30, 2026
Status: Posted
CFDA Numbers: 12.420
DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial Award
Deadline: September 30, 2026
Opportunity Number: HT942526ALSRPPCTA
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: September 30, 2026
Status: Posted
CFDA Numbers: 12.420
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award
Deadline: September 30, 2026
Opportunity Number: HT942526ALSRPTDA
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: September 30, 2026
Status: Posted
CFDA Numbers: 12.420
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
Deadline: September 30, 2026
Opportunity Number: HT942526ALSRPTIA
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: September 30, 2026
Status: Posted
CFDA Numbers: 12.420
DoW Breast Cancer, Breakthrough Award Level 3
Deadline: September 30, 2026
Opportunity Number: HT942526BCRPBTA3
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: September 30, 2026
Status: Posted
CFDA Numbers: 12.420
DoW Breast Cancer, Breakthrough Award Level 4
Deadline: September 30, 2026
Opportunity Number: HT942526BCRPBTA4
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: September 30, 2026
Status: Posted
CFDA Numbers: 12.420
DoW Breast Cancer, Breakthrough Award Levels 1 and 2
Deadline: July 8, 2026
Opportunity Number: HT942526BCRPBTA12
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: July 8, 2026
Status: Posted
CFDA Numbers: 12.420
DoW Breast Cancer, Clinical Research Extension Award
Deadline: July 8, 2026
Opportunity Number: HT942526BCRPCREA
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: July 8, 2026
Status: Posted
CFDA Numbers: 12.420
DoW Breast Cancer, Era of Hope Scholar Award
Deadline: July 8, 2026
Opportunity Number: HT942526BCRPEOHS
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: July 8, 2026
Status: Posted
CFDA Numbers: 12.420
DoW Breast Cancer, Transformative Breast Cancer Consortium Award
Deadline: September 30, 2026
Opportunity Number: HT942526BCRPTBCCA
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: September 30, 2026
Status: Posted
CFDA Numbers: 12.420
DoW Breast Cancer, Transformative Breast Cancer Consortium Development Award
Deadline: July 8, 2026
Opportunity Number: HT942526BCRPTBCCDA
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: July 8, 2026
Status: Posted
CFDA Numbers: 12.420
DoW Hearing Restoration Focused Research Award
Deadline: September 10, 2026
Opportunity Number: HT942526HRRPFRA
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: September 10, 2026
Status: Posted
CFDA Numbers: 12.420
DoW Ovarian Cancer, Clinical Trial Award
Deadline: October 1, 2026
Opportunity Number: HT942526OCRPCTA
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: October 1, 2026
Status: Posted
CFDA Numbers: 12.420
DoW Pancreatic Cancer Research Program, Focused Pilot Award
Deadline: October 7, 2026
Opportunity Number: HT942526PCARPFPTA
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: October 7, 2026
Status: Posted
CFDA Numbers: 12.420
DoW Pancreatic Cancer Research Program, Idea Development Award
Deadline: October 7, 2026
Opportunity Number: HT942526PCARPIDA
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: October 7, 2026
Status: Posted
CFDA Numbers: 12.420
DoW Pancreatic Cancer Research Program, Translational Research Partnership Award
Deadline: October 7, 2026
Opportunity Number: HT942526PCARPTRPA
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: October 7, 2026
Status: Posted
CFDA Numbers: 12.420
DoW, Ovarian Cancer, Investigator-Initiated Research Award
Deadline: October 1, 2026
Opportunity Number: HT942526OCRPIIRA
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: October 1, 2026
Status: Posted
CFDA Numbers: 12.420
DoW, Ovarian Cancer, Ovarian Cancer Academy – Early-Career Investigator Award
Deadline: October 1, 2026
Opportunity Number: HT942526OCRPOCAECI
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: October 1, 2026
Status: Posted
CFDA Numbers: 12.420
DoW, Ovarian Cancer, Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award
Deadline: October 1, 2026
Opportunity Number: HT942526OCRPOCCTAECI
Agency: Dept. of the Army -- USAMRAA
Open Date: May 4, 2026
Close Date: October 1, 2026
Status: Posted
CFDA Numbers: 12.420